Procalcitonin's role in the sepsis cascade. Is procalcitonin a sepsis marker or mediator?

Minerva Anestesiologica

Volumn 75, Issue 7-8, 2009, Pages 447-452

  Dahaba, A A ^a   Metzler, H ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Inflammation; Procalcitonin; Sepsis

Indexed keywords

PROCALCITONIN;

AMINO ACID SEQUENCE; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HORMONE RELEASE; HUMAN; INTENSIVE CARE UNIT; NOTE; POSTOPERATIVE CARE; SEPSIS; SEPTIC SHOCK;

BIOLOGICAL MARKERS; CALCITONIN; HUMANS; PREDICTIVE VALUE OF TESTS; PROTEIN PRECURSORS; SEPSIS; SURVIVAL; TREATMENT OUTCOME;

EID: 69149086176     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (32)

1. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D et al. Members of the Society of Critical Care Medicine (SCCM)/European Society of Intensive Care medicine (ESICM)/American College of Chest Physicians (ACCP)/American Thoracic society (ATS)/Surgical Infection Society (SIS). 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003:31: 1250-1256
2. Bone RC. The pathogenesis of sepsis. Ann Intern Med 1991;115:457-469
3. Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, Dupont E. Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality Chest 1993;103:555-575
4. Oberhoffer M, Vogelsang H, Rußwurm S, Hartung T, Reinhart K. Outcome prediction by traditional and new markers of inflammation in patients with sepsis. Clin Chem Lab Med 1999:37:363-368 (Pubitemid 29209753)
5. Reinhart K, Karzai W, Meisner M. Procalcitonin as a marker of the systemic inflammatory response to infection. Intensive Care Med 2000;26:1193-1200 (Pubitemid 30743878)
6. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993;341:515-518 (Pubitemid 23066085)
7. Nylen ES, Whang KT, Snider RH Jr, Steinwald PM, White JC, Becker KL. Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit Care Med 1998;26:1001-1006
8. Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections. Cluster-randomised, single-blinded intervention trial. Lancet 2004;363:600-607
9. O'Grady NP, Barie PS, Bartlett JG, Bleck T, Carroll K, Kalil AC et al. Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of America. Crit Care Med 2008;36:1330-1349
10. Le Moullec JM, Jullienne A, Chenais J, Lasmolas F, Guilana JM, Milhaud G et al. The complete sequence of human pre-procalcitonin. FEBS 1984;167:93-97
11. Mueller B, White JC, Nylen ES, Snider RH, Becker KL, Habener JF Ubiquitous expression of the calcitonin-1 gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab 2001;86:396-404.
12. Mueller B, Becker KL. Procalcitonin: how a hormone became a marker and mediator of sepsis. Swiss Med Wkly 2001;131: 595-602.
13. Becker KL, Nylen ES, Snider RH, Mueller B, White JC. Immunoneutralization of procalcitonin as therapy of sepsis. J Endotoxin Res 2003;9:367-374
14. Tschaikowsky K, Hedwig-Geissing M, Schiele A, Bremer F, Schywalsky M, Schüttler J. Coincidence of pro- and anti-inflammatory responses in the early phase of severe sepsis: Longitudinal study of mononuclear histocompatibility leukocyte antigen-DR expression, procalcitonin, C-reactive protein, and changes in T-cell subsets in septic and postoperative patients. Crit Care Med 2002;30:1015-1023 (Pubitemid 34508022)
15. Monneret G, Laroche B, Bienvenu J. Procalcitonin is not produced by circulating blood cells. Infection 1998:27:34-5. (Pubitemid 29054377)
16. Dandona P, Nix D, Wilson MF, Aljada A, Love J, Assicot M et al. Procalcitonin increase after endotoxin injection in normal subjects J Clin Endocrinol Metab 1994;79:1605-1608
17. Kettelhack C, Hohenberger P, Schulze G, Kilpert B, Schlag P. Induction of systemic serum procalcitonin and cardiocirculatory reactions after isolated limb perfusion with recombinant human tumor necrosis factor- and melphalan. Crit Care Med 2000;28:1040-1046 (Pubitemid 30262075)
18. Nijsten MW, Olinga P, The TH, de Vries EG, Koops HS, Groothuis GM et al. Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med 2000;28:458-461
19. Steinwald PM, Whang KT, Becker KL, Snider RH, Nylen ES, White JC. Elevated calcitonin precursor levels are related to mortality in an animal model of sepsis. Crit Care 1999:3:11-16
20. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 1995:273:117-123
21. Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau GE et al. and the Geneva Sepsis Network. Diagnostic value of procalcitonin, interleukin-6 and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001;164:396-402.
22. Al-Nawas B, Krammer I, Shah PM. Procalcitonin in diagnosis of severe infections Eur J Med Res 1996;1:331-333
23. Reith HB, Mittelkoetter U, Debus ES, Kuessner C, Thieda A. Procalcitonin in early detection of postoperative complications. Dig Surg 1998;15:260-265
24. Schroeder J, Staubach KH, Zabel P, Stueber F, Kremer B. Procalcitonin as a marker of severity in septic shock. Langenbeck's Arch Surg 1999:384:33-38 (Pubitemid 29225315)
25. Vincent JL, de Mendonca A, Cantraine F, Moreno R, Takala J, Suter PM et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Crit Care Med 1998:26:1793-800. (Pubitemid 28527688)
26. Meisner M, Tschaikowsky K, Palmaers T, Schmidt J. Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Critical Care 1999:3:45-50. (Pubitemid 29304058)
27. Wagner KE, Martinez JM, Vath SD, Snider RH, Nylen ES, Becker KL et al. Early immunoneutralization of calcitonin precursors attenuates the adverse physiologic response to sepsis in pigs. Crit Care Med 2002;30:2313-2321
28. Martinez JM, Wagner KE, Snider RH, Nylen ES, Mueller B, Sarani B et al. Late immunoneutralization of procalcitonin arrests the progression of lethal porcine sepsis. Surg Infect 2001;2:193-203. (Pubitemid 34065559)
29. Whang KT, Vath SD, Becker KL, Snider RH, Nylen ES, Muller B et al. Procalcitonin and proinflammatory cytokine interactions in sepsis. Shock 2000;14:73-78
30. Dahaba AA, Hagara B, Fall A, Rehak PH, List WF, Metzler H. Procalcitonin for early prediction of survival outcome in postoperative critically ill patients with severe sepsis. Br J Anaesth 2006;97:503-508 (Pubitemid 44419965)
31. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36.
32. Von Heimburg D, Stieghorst W, Khorram-Sefat R, Pallua N. Procalcitonin: a sepsis parameter in severe burn injuries. Burns 1998;24:745-750 (Pubitemid 29022845)